You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/71199
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHaddad, Marcela Filié-
dc.contributor.authorTakamiya, Aline Satie-
dc.contributor.authorda Silva, Eulália Maria Martins-
dc.contributor.authorBarbosa, Débora de Barros-
dc.date.accessioned2014-05-27T11:24:00Z-
dc.date.accessioned2016-10-25T18:27:30Z-
dc.date.available2014-05-27T11:24:00Z-
dc.date.available2016-10-25T18:27:30Z-
dc.date.issued2009-10-19-
dc.identifierhttp://dx.doi.org/10.4321/S1134-928X2009000100004-
dc.identifier.citationGerokomos, v. 20, n. 1, p. 22-27, 2009.-
dc.identifier.issn1134-928X-
dc.identifier.urihttp://hdl.handle.net/11449/71199-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/71199-
dc.description.abstractIntroduction: It was observed a considerable growth of elderly people. They are who use more medicines. The physiological changes associated with the age advancing can make pharmacokinetic and pharmacodynamic alterations. The cognitive decline, physical limitations and associate chronic pathology affect the medications appropriately use ability. Aims: Based in a literature review, appoint the main pharmacological groups prescribed to the elderly and the drug-drug interaction risks. Conclusion: The most of elderly use continually at least 3 medicines, the most prescribed are to cardiovascular and psychic diseases treatment.en
dc.format.extent22-27-
dc.language.isospa-
dc.sourceScopus-
dc.subjectContinuous use medicines-
dc.subjectDrug-drug interaction-
dc.subjectElderly-
dc.subjectacetylsalicylic acid-
dc.subjectamitriptyline-
dc.subjectanalgesic agent-
dc.subjectantacid agent-
dc.subjectantihypertensive agent-
dc.subjectantiinflammatory agent-
dc.subjectantiulcer agent-
dc.subjectanxiolytic agent-
dc.subjectbeta adrenergic receptor blocking agent-
dc.subjectbromazepam-
dc.subjectcalcium channel blocking agent-
dc.subjectchlordiazepoxide-
dc.subjectchlorpropamide-
dc.subjectclomipramine-
dc.subjectdiazepam-
dc.subjectdiclofenac-
dc.subjectdiltiazem-
dc.subjectdipeptidyl carboxypeptidase inhibitor-
dc.subjectdiuretic agent-
dc.subjectflurazepam-
dc.subjectfurosemide-
dc.subjectheparin-
dc.subjectmethyldopa-
dc.subjectmineral-
dc.subjectneuroleptic agent-
dc.subjectnifedipine-
dc.subjectnitrazepam-
dc.subjectphenylbutazone-
dc.subjectunindexed drug-
dc.subjectvitamin-
dc.subjectaged-
dc.subjectaging-
dc.subjectcardiovascular disease-
dc.subjectdrug safety-
dc.subjectdrug use-
dc.subjectelderly care-
dc.subjecthuman-
dc.subjectmental disease-
dc.subjectpharmacodynamics-
dc.subjectprescription-
dc.subjectrisk assessment-
dc.subjectsocial psychology-
dc.subjectunspecified side effect-
dc.titleFarmacología en la tercera edad: Medicamentos de uso continuo y peligros de la interacción medicamentosaes
dc.title.alternativePharmacology in the elderly: Continuous use medicines and drug-drug interaction risksen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationFacultad de Odontología de Araçatuba (FOA) UNESP, Rua José Bonifácio 1193, Vila Mendonça 16015-050-
dc.description.affiliationDepartamento de Materiales Odontológicos y Prótesis Facultad de Odontología de Araçatuba (FOA) UNESP, Rua José Bonifácio 1193, Vila Mendonça 16015-050-
dc.description.affiliationUnespFacultad de Odontología de Araçatuba (FOA) UNESP, Rua José Bonifácio 1193, Vila Mendonça 16015-050-
dc.description.affiliationUnespDepartamento de Materiales Odontológicos y Prótesis Facultad de Odontología de Araçatuba (FOA) UNESP, Rua José Bonifácio 1193, Vila Mendonça 16015-050-
dc.identifier.doi10.4321/S1134-928X2009000100004-
dc.identifier.scieloS1134-928X2009000100004-
dc.rights.accessRightsAcesso aberto-
dc.identifier.file2-s2.0-70349976092.pdf-
dc.relation.ispartofGerokomos-
dc.identifier.scopus2-s2.0-70349976092-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.